CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...

The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve months ending in March 2016 Dr Reddy’s Laboratories (DRL) has launched ...

GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...

THE value of sublingual administration of nitroglycerin for relief of attacks of angina pectoris is well established. Nitroglycerin has also been advocated as a prophylactic — before exercise and so ...

GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...

Dr Reddy's Laboratories today said it has launched nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Glenmark Pharmaceuticals on Monday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used for preventing chest pain due to coronary artery disease.

Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (USFDA) to market Nitroglycerin Sublingual tablets in the strengths of 0.3 mg, 0.4mg and 0.6mg. The drug is ...

Oslo, November 20, 2017 - Navamedic ASA (NAVA.OL), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a preliminary long-term agreement with G. Pohl-Boskamp ...

New Delhi: Drug firm Natco Pharma Wednesday said its marketing partner Alvogen has received final ANDA nod from USFDA for chest pain tablets. "The company is pleased to announce that its marketing ...

Dr. Reddy’s Laboratories Ltd has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in ...